Drugs / Keverprazan
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06777732 | Mar → Sep 2025 overdue | Helicobacter pylori infectious disease | Nanjing First Hospital, Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06760065 | Jan 2025 → Dec 2027 expected | Helicobacter pylori infectious disease | Sixth Affiliated Hospital, Sun Yat-sen University | Not yet recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06412640 | Jun → Dec 2024 | Helicobacter pylori infectious disease | Nanjing First Hospital, Nanjing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT07122024 | Feb 2024 → Aug 2025 overdue | Helicobacter pylori infectious disease | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06851468 | Mar → Nov 2025 | Helicobacter pylori infectious disease | Key Laboratory for Gastrointestinal Diseases of Gansu Province | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06734260 Comparator | Sep 2024 → Nov 2025 overdue | — | Eighth Affiliated Hospital, Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Keverprazan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07122024 ↗ |
| Known as | Keverprazan Hydrochloride | “Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral” NCT06734260 ↗ |
| Action | Inhibit | “stronger and longer inhibition effect on gastric acid compared with PPIs” NCT06734260 ↗ |
| Route | Oral | “Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral” NCT06734260 ↗ |